8 [49] H. M. Lander, D. P. Hajjar, B. L. Hempstead et al., “A molecular redox switch on p21(ras). Structural basis for the nitric oxide- p21(ras) interaction,” Journal of Biological Chemistry, vol. 272, no. 7, pp. 4323–4326, 1997. [50] H. M. Lan dˇer, A. J. Mllbank, J. M. Tauras et al., “Redox reg- ulation of cell signalling,” Nature, vol. 381, no. 6581, pp. 380– 381, 1996. [51] H. M. Lander, J. S. Ogiste, S. F. A. Pearce, R. Levi, and A. Novogrodsky, “Nitric oxide-stimulated guanine nucleotide exchange on p21(ras),” Journal of Biological Chemistry, vol. 270, no. 13, pp. 7017–7020, 1995. [52] H. M. Lander, P. K. Sehajpal, and A. Novogrodsky, “Nitric oxide signaling: a possible role for G proteins,” Journal of Immunology, vol. 151, no. 12, pp. 7182–7187, 1993. [53] A. P. Saavedra, O. M. Tsygankova, G. V. Prendergast, J. H. Dworet, G. Cheng, and J. L. Meinkoth, “Role of cAMP, PKA and Rap1A in thyroid follicular cell survival,” Oncogene, vol. 21, no. 5, pp. 778–788, 2002. [54] D. Mittar, P. K. Sehajpal, and H. M. Lander, “Nitric oxide activates Rap1 and Ral in a Ras-independent manner,” Bio- chemical and Biophysical Research Communications, vol. 322, no. 1, pp. 203–209, 2004. [55] H. M. Lander, J. M. Tauras, J. S. Ogiste, O. Hori, R. A. Moss, and A. M. Schmidt, “Activation of the receptor for advanced glycation end products triggers a p21(ras)-de- pendent mitogen-activated protein kinase pathway regulated by oxidant stress,” Journal of Biological Chemistry, vol. 272, no. 28, pp. 17810–17814, 1997. [56] J. Heo and S. L. Campbell, “Mechanism of p21Ras S-ni- trosylation and kinetics of nitric oxide-mediated guanine nu- cleotide exchange,” Biochemistry, vol. 43, no. 8, pp. 2314–2322, 2004. [57] J. Heo, K. C. Prutzman, V. Mocanu, and S. L. Campbell, “Mechanism of free radical nitric oxide-mediated Ras guanine nucleotide dissociation,” Journal of Molecular Biology, vol. 346, no. 5, pp. 1423–1440, 2005. [58] J. Heo and S. L. Campbell, “Superoxide anion radical modu- lates the activity of Ras and Ras-related GTPases by a radical- based mechanism similar to that of nitric oxide,” Journal of Biological Chemistry, vol. 280, no. 13, pp. 12438–12445, 2005. [59] J. Heo and S. L. Campbell, “Mechanism of redox-mediated guanine nucleotide exchange on redox-active Rho GTPases,” Journal of Biological Chemistry, vol. 280, no. 35, pp. 31003– 31010, 2005. [60] J. Heo, K. W. Raines, V. Mocanu, and S. L. Campbell, “Redox regulation of RhoA,” Biochemistry, vol. 45, no. 48, pp. 14481– 14489, 2006. [61] A. Aghajanian, E. S. Wittchen, S. L. Campbell, and K. Bur- ridge, “Direct activation of RhoA by reactive oxygen species requires a redox-sensitive motif,” PLoS ONE, vol. 4, no. 11, p. e8045, 2009. [62] J. Heo, “Redox regulation of Ran GTPase,” Biochemical and Biophysical Research Communications, vol. 376, no. 3, pp. 568– 572, 2008. [63] O. L. Hordijk, “Regulation of NADPH oxidases: the role of Rac proteins,” Circulation Research, vol. 98, no. 4, pp. 453–462, 2006. [64] D. Harrison, K. K. Griendling, U. Landmesser, B. Hornig, and H. Drexler, “Role of oxidative stress in atherosclerosis,” American Journal of Cardiology, vol. 91, no. 3, pp. 7A–11A, 2003. [65] B. Lasse`gue and R. E. Clempus, “Vascular NAD(P)H oxi- dases: speciﬁc features, expression, and regulation,” American Journal of Signal Transduction Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 285, no. 2, pp. R277–R297, 2003. [66] N. R. Madamanchi, A. Vendrov, and M. S. Runge, “Oxidative stress and vascular disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 1, pp. 29–38, 2005. [67] D. Gregg, F. M. Rauscher, and P. J. Goldschmidt-Clermont, “Rac regulates cardiovascular superoxide through diverse mo- lecular interactions: more than a binary GTP switch,” Ameri- can Journal of Physiology—Cell Physiology, vol. 285, no. 4, pp. C723–C734, 2003. [68] P. N. Seshiah, D. S. Weber, P. Rocic, L. Valppu, Y. Taniyama, and K. K. Griendling, “Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators,” Circulation Research, vol. 91, no. 5, pp. 406–413, 2002. [69] L. Zuo, M. Ushio-Fukai, S. Ikeda, L. Hilenski, N. Patrushev, and R. W. Alexander, “Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 9, pp. 1824– 1830, 2005. [70] M. A. del Pozo, N. Balasubramanian, N. B. Alderson et al., “Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization,” Nature Cell Biology, vol. 7, no. 9, pp. 901–908, 2005. [71] C. Vecchione, E. Patrucco, G. Marino et al., “Protection from angiotensin II-mediated vasculotoxic and hypertensive re- sponse in mice lacking PI3Kγ,” Journal of Experimental Med- icine, vol. 201, no. 8, pp. 1217–1228, 2005. [72] M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44– 84, 2007. [73] K. S. Kim, K. Takeda, R. Sethi et al., “Protection from reox- ygenation injury by inhibition of Rac1,” Journal of Clinical Investigation, vol. 101, no. 9, pp. 1821–1826, 1998. [74] N. Harada, Y. Iimuro, T. Nitta et al., “Inactivation of the small GTPase Rac1 protects the liver from ischemia/reperfusion injury in the rat,” Surgery, vol. 134, no. 3, pp. 480–491, 2003. [75] A. A. Andreadis, S. L. Hazen, S. A. A. Comhair, and S. C. Er- zurum, “Oxidative and nitrosative events in asthma,” Free Radical Biology and Medicine, vol. 35, no. 3, pp. 213–225, 2003. [76] K. F. Rabe, G. Dent, and H. Magnussen, “Hydrogen perox- ide contracts human airways in vitro: role of epithelium,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 269, no. 3, pp. L332–L338, 1995. [77] K. Kojima, H. Kume, S. Ito et al., “Direct eﬀects of hydrogen peroxide on airway smooth muscle tone: roles of Ca2+ inﬂux and Rho-kinase,” European Journal of Pharmacology, vol. 556, no. 1–3, pp. 151–156, 2007. [78] L. Jin, Z. Ying, and R. C. Webb, “Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 287, no. 4, pp. H1495–H1500, 2004. [79] D. Hanahan and R. A. Weinberg, “The hallmarks of cancer,” Cell, vol. 100, no. 1, pp. 57–70, 2000. [80] Y. Hu, W. Lu, G. Chen et al., “K-rasG12V transformation leads to mitochondrialdysfunction and a metabolic switch from oxidative phosphorylation to glycolysis,” Cell Research. In press. [81] F. Weinberg, R. Hamanaka, W. W. Wheaton et al., “Mitochon- drial metabolism and ROS generation are essential for Kras- mediated tumorigenicity,” Proceedings of the National Academy